Member Info for M_Night

Hard to say, but he's posted something!

https://twitter.com/carlsmythe/status/1363157998818848772

At 3-7p, most of us here are in this quite early.

Check out the team on their website. They have a lot of great expertise and the people spearheading this ain't no shmucks.

On youtube, there's an interview with Nicole Godresse, who's the chief sales office. More importantly she was previously the sales Director at Tilray.

I'm confident this is going north of 10p sooner or later and beyond 20p given enough time.

That's crazy, so much buzz for something that's been tested on just 30 samples. Check out the RNS for BH from Jan, stated 500 clinical samples......

Lockdown easing and the AVCT test!

The key attributes for the testing device that we have determined are as follows:

Simple swab or saliva sample - no clinical expertise needed
No complex sample preparation - proprietary single-use cartridge containing analytes
Simple portable reader - shoebox size
No clinical training needed - automated test can be used in any location
Rapid result - sample to result in 5 to 10 minutes, potential for further reduction
yes/no result - option for quantification of viral load
Platform technology - can potentially be used to detect multiple virus targets

Not trying to ramp here, but looking to the positives...

The lead man, Carl Smythe, remains fairly chirpy on twitter, his name still references the test and he tweeted a pic of the test with what seemingly was the 'greenlight'.

Paraytec have also been vocal about it on their twitter this week.

Braveheart's RNS gave an optimistic tone.

The test isn't limited to Covid.

They've set a high bar and so even if they're a little off the mark, it'd have to be a colossal failure for it not to be positive overall regardless if it ends up the market leader or not.

With all that considered and the fact that big investors have stayed in after back to back blue days leads me to believe we could be in for a nice surprise. Perhaps not thunderous such as 200-500% in a matter of days, but good news to gradually build upon.

So I'm under the impression they're being taken over and then entering a new domain that'll be floated?

It seems with the successful phase II results of ArtemiiC, this gives them licence to sell it as a food supplement as the recent deal states. However, they're going to continue with phase III, as successful results would mean it can be distributed clinically too....?

I can't see any line stating it being distributed as a food supplement is dependent on successful phase III trials...

Thanks all! Will look for this recap and begin looking into this more. On the surface all sounds quite promising.

Hi all, this looks like a great opportunity. Could anyone give me a few key points that are expected over the next few months that will swing this back the over way? I'll then do my own research and go from there!

Cheers.
M

Just my guess. Might struggle to really smash 1.20 until the end of today.

What say ya'll?

@paraytec1
@Paraytec1
Paraytec has partnered in this work with Professor
@carlsmythe

and his team at the University of Sheffield to provide the proprietary microbiology aspects that are required, with the hardware and software developed by Paraytec. https://paraytec.com/about/covid19-test/
4:00 pm · 18 Feb 2021·Twitter Web App

!!!

Ignore him.

I looked on Carl's twitter, BH and PT and can't find anything.....

hmmmm

Overtime the natural progression of this is north, pumpers or not, especially now with the news and their future pipeline and market segment. Do check out the investor presentation and do some research and you'll see the future is bright for this. I'm holding this for 20, 30, 40, 50+p over the next year or two.

not for quick gains...imo.

Given how much Jazz paid for GWP, another medically focused cannabis, you'd think a competitor will want to swallow this up...